We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Off-Label Stent Use May Be Restricted in Wake of FDA Meeting
Off-Label Stent Use May Be Restricted in Wake of FDA Meeting
January 3, 2007
After examining risks related to the off-label use of drug-eluting stents, an FDA advisory panel last month recommended the agency consider mandating labeling changes.